Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2026,
Ramkhamhaeng Hospital PCL paid฿0 Mil more to buy back shares than it received from issuing new shares.
It spent฿331 Mil paying down its debt.
It paid฿0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received฿0 Mil from paying cash dividends to shareholders.
It spent฿151 Mil on other financial activities.
In all, Ramkhamhaeng Hospital PCLspent฿483 Mil on financial activities for the
three
months ended in Mar. 2026.
Ramkhamhaeng Hospital PCL (BKK:RAM) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Ramkhamhaeng Hospital PCL's issuance of stock for the
three
months ended in Mar. 2026 was ฿0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Ramkhamhaeng Hospital PCL's repurchase of stock for the
three
months ended in Mar. 2026 was ฿0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Ramkhamhaeng Hospital PCL's net issuance of debt for the
three
months ended in Mar. 2026 was ฿-331 Mil.
Ramkhamhaeng Hospital PCL spent฿331 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Ramkhamhaeng Hospital PCL's net issuance of preferred for the
three
months ended in Mar. 2026 was ฿0 Mil.
Ramkhamhaeng Hospital PCL paid฿0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Ramkhamhaeng Hospital PCL's cash flow for dividends for the
three
months ended in Mar. 2026 was ฿0 Mil.
Ramkhamhaeng Hospital PCL received฿0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Ramkhamhaeng Hospital PCL's other financing for the
three
months ended in Mar. 2026 was ฿-151 Mil.
Ramkhamhaeng Hospital PCL spent฿151 Mil on other financial activities.
Ramkhamhaeng Hospital PCL Cash Flow from Financing Related Terms
Ramkhamhaeng Hospital PCL Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Ramkhamhaeng Hospital PCL's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramkhamhaeng Hospital PCL Cash Flow from Financing Chart
Ramkhamhaeng Hospital PCL Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Ramkhamhaeng Hospital PCL's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-3,357 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of ฿-3,357 Mil mean?
Ramkhamhaeng Hospital PCL (BKK:RAM) has a Cash Flow from Financing of ฿-3,357 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ramkhamhaeng Hospital PCL and its competitors.
Is Ramkhamhaeng Hospital PCL's Cash Flow from Financing too high?
Ramkhamhaeng Hospital PCL's current Cash Flow from Financing is ฿-3,357 Mil. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's Cash Flow from Financing compare to HCA and THC?
Ramkhamhaeng Hospital PCL's Cash Flow from Financing of ฿-3,357 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Ramkhamhaeng Hospital PCL and its competitors. Ramkhamhaeng Hospital PCL's current Cash Flow from Financing is ฿-3,357 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿45.41, compared to a current price of ฿17.90 — trading 60.6% below its estimated fair value. The current Cash Flow from Financing is ฿-3,357 Mil. Ramkhamhaeng Hospital PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current Cash Flow from Financing is ฿-3,357 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.90 is trading 60.6% below its estimated GF Value™ of ฿45.41.
GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:RAM:
Cash Flow from Financing: ฿-3,357 Mil
GF Value™: ฿45.41 vs. price of ฿17.90 (60.6% below fair value)
No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
77GF Score
Get the complete analysis for BKK:RAM
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM has been successfully added to your 
